BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 20041844)

  • 21. Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT.
    De Francesco EM; Maggiolini M; Musti AM
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29996493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithin, a target of transforming growth factor-beta signaling, mediates epithelial-mesenchymal transition.
    Lee HS; Kim C; Kim SB; Kim MG; Park D
    Biochem Biophys Res Commun; 2010 May; 395(4):553-9. PubMed ID: 20398629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of epithelial-mesenchymal transition in cancer pathology.
    Guarino M; Rubino B; Ballabio G
    Pathology; 2007 Jun; 39(3):305-18. PubMed ID: 17558857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Akt and Notch pathways mediate polyhexamethylene guanidine phosphate-induced epithelial-mesenchymal transition via ZEB2.
    Jeong MH; Kim HR; Park YJ; Chung KH
    Toxicol Appl Pharmacol; 2019 Oct; 380():114691. PubMed ID: 31348943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. α-Mangostin-encapsulated PLGA nanoparticles inhibit colorectal cancer growth by inhibiting Notch pathway.
    Chandra Boinpelly V; Verma RK; Srivastav S; Srivastava RK; Shankar S
    J Cell Mol Med; 2020 Oct; 24(19):11343-11354. PubMed ID: 32830433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ERK1/2 pathway mediates epithelial-mesenchymal transition by cross-interacting with TGFβ/Smad and Jagged/Notch signaling pathways in lens epithelial cells.
    Chen X; Ye S; Xiao W; Wang W; Luo L; Liu Y
    Int J Mol Med; 2014 Jun; 33(6):1664-70. PubMed ID: 24714800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of Notch Signaling Pathway as an Effective Chemosensitizer for Cancer Treatment.
    Majidinia M; Alizadeh E; Yousefi B; Akbarzadeh M; Zarghami N
    Drug Res (Stuttg); 2016 Nov; 66(11):571-579. PubMed ID: 27701712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Notch signaling pathway in cancer: from mechanistic insights to targeted therapies.
    Shi Q; Xue C; Zeng Y; Yuan X; Chu Q; Jiang S; Wang J; Zhang Y; Zhu D; Li L
    Signal Transduct Target Ther; 2024 May; 9(1):128. PubMed ID: 38797752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype.
    Boareto M; Jolly MK; Goldman A; Pietilä M; Mani SA; Sengupta S; Ben-Jacob E; Levine H; Onuchic JN
    J R Soc Interface; 2016 May; 13(118):. PubMed ID: 27170649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application.
    Yuan X; Wu H; Han N; Xu H; Chu Q; Yu S; Chen Y; Wu K
    J Hematol Oncol; 2014 Dec; 7():87. PubMed ID: 25477004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Notch pathway in colorectal cancer.
    Vinson KE; George DC; Fender AW; Bertrand FE; Sigounas G
    Int J Cancer; 2016 Apr; 138(8):1835-42. PubMed ID: 26264352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epithelial-mesenchymal transition in cancer development and its clinical significance.
    Iwatsuki M; Mimori K; Yokobori T; Ishi H; Beppu T; Nakamori S; Baba H; Mori M
    Cancer Sci; 2010 Feb; 101(2):293-9. PubMed ID: 19961486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HMGA2 Modulates the TGFβ/Smad, TGFβ/ERK and Notch Signaling Pathways in Human Lens Epithelial-Mesenchymal Transition.
    Hou M; Bao X; Luo F; Chen X; Liu L; Wu M
    Curr Mol Med; 2018; 18(2):71-82. PubMed ID: 29974827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Notch signaling mediates TGF-β1-induced epithelial-mesenchymal transition through the induction of Snai1.
    Matsuno Y; Coelho AL; Jarai G; Westwick J; Hogaboam CM
    Int J Biochem Cell Biol; 2012 May; 44(5):776-89. PubMed ID: 22330899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the epithelial-to-mesenchymal transition clinically relevant for the cancer patient?
    Krasnapolski MA; Todaro LB; de Kier Joffé EB
    Curr Pharm Biotechnol; 2011 Nov; 12(11):1891-9. PubMed ID: 21470129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epithelial-mesenchymal transitions in cancer onset and progression].
    Thiery JP
    Bull Acad Natl Med; 2009 Dec; 193(9):1969-78; discussion 1978-9. PubMed ID: 20666011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CLDN-1 promoted the epithelial to migration and mesenchymal transition (EMT) in human bronchial epithelial cells via Notch pathway.
    Lv J; Sun B; Mai Z; Jiang M; Du J
    Mol Cell Biochem; 2017 Aug; 432(1-2):91-98. PubMed ID: 28316062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.
    McConkey DJ; Choi W; Marquis L; Martin F; Williams MB; Shah J; Svatek R; Das A; Adam L; Kamat A; Siefker-Radtke A; Dinney C
    Cancer Metastasis Rev; 2009 Dec; 28(3-4):335-44. PubMed ID: 20012924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Notch Signaling Function in the Angiocrine Regulation of Tumor Development.
    Trindade A; Duarte A
    Cells; 2020 Nov; 9(11):. PubMed ID: 33198378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.